LITAZONE 30 pioglitazone (as hydrochloride) 30mg tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

pioglitazone hydrochloride, Quantity: 33.072 mg (Equivalent: pioglitazone, Qty 30 mg)

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

Pioglitazone hydrochloride

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: lactose monohydrate; carmellose calcium; hyprolose; magnesium stearate

Via di somministrazione:

Oral

Confezione:

7 tablets, 28 tablets, 50 tablets, 98 tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Treatment of type 2 diabetes inadequately controlled by diet and exercise: ? As monotherapy ? As dual therapy to improve glycaemic control - In combination with metformin or sulfonylurea - In combination with insulin ? As triple therapy to improve glycaemic control - In combination with metformin and sulfonylurea

Dettagli prodotto:

Visual Identification: White to off white, round, flat faced beveled edge uncoated tablets debossed with break-line separating '11' and '19' on one side and break-line on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2011-10-26